Effective Treatment for Small-Cell Lung Cancer
Author Information
Author(s): Eberhardt W, Stamatis G, Stuschke M, Wilke H, Müller M R, Kolks S, Flasshove M, Schütte J, Stahl M, Schlenger L, Budach V, Greschuchna D, Stüben G, Teschler H, Sack H, Seeber S
Primary Institution: West German Cancer Center, University of Essen Medical School
Hypothesis
Can a multimodality treatment approach improve outcomes for small-cell lung cancer patients?
Conclusion
The multimodality treatment including surgery was highly effective, showing significant long-term survival rates in patients with small-cell lung cancer.
Supporting Evidence
- 94% of patients showed an objective response to the treatment.
- 72% of patients planned for surgery were completely resected.
- The median survival for all patients was 36 months.
- The 5-year survival rate for all patients was 46%.
- R0 patients had a median survival of 68 months.
Takeaway
Doctors used a combination of treatments to help patients with a type of lung cancer, and many of them lived much longer after the treatment.
Methodology
Patients received a combination of chemotherapy, radiation, and surgery based on their cancer stage.
Limitations
The study had a small sample size and limited follow-up for some patients.
Participant Demographics
Patients included those with small-cell lung cancer stages IB to IIIB.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website